Acute effects of intravenous trapidil on hemodynamics, coronary circulation and myocardial metabolism in man. 1983

Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue

The acute effects of intravenous trapidil on hemodynamics, coronary circulation and myocardial metabolism were evaluated in 19 patients (Group I: 10 patients of chest pain syndrome; Group II: 9 patients of coronary heart disease). The heart rate increased (p less than 0.05) and aortic pressure decreased (p less than 0.01) during a 6-min study period. Pulmonary arterial end-diastolic pressure decreased slightly in both groups and cardiac output increased prominently in Group II. Myocardial oxygen consumption did not change significantly 3 and 6 min after trapidil injection. Coronary sinus flow increased slightly (statistically not significant) despite a decrease in aortic pressure, and thus, coronary vascular resistance decreased significantly in both groups. Coronary A-V O2 difference decreased 3 min after trapidil injection and no significant change in the lactate extraction ratio was observed. The diameter of the left main coronary artery increased by about 6% after an administration of trapidil. These results suggest that trapidil has the beneficial effect of coronary vasodilation and it increases cardiac output, despite a decrease in the preload, without a significant increase in myocardial oxygen consumption. The latter may be due to an afterload reduction effect of this drug.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females

Related Publications

Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
May 1987, Kokyu to junkan. Respiration & circulation,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
July 1985, Archives des maladies du coeur et des vaisseaux,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
January 1985, Arzneimittel-Forschung,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
December 1958, Minerva chirurgica,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
January 1983, Therapie,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
July 1959, Annals of internal medicine,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
January 1976, Recent advances in studies on cardiac structure and metabolism,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
August 1969, Archives des maladies du coeur et des vaisseaux,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
January 1984, Arzneimittel-Forschung,
Y Koretsune, and K Kodama, and S Nanto, and K Ishikawa, and K Taniura, and M Mishima, and M Hori, and M Inoue
August 1981, Circulation,
Copied contents to your clipboard!